Emerging evidence connects geranylgeranoic acid to enhanced sperm maturation and fertility, suggesting physiological roles in male reproductive health.
Geranylgeranoic acid (GGA) is a naturally occurring C20 isoprenoid lipid that has garnered attention for its anticancer and retinoid-like properties. While its hepatic functions are well documented, its role in male reproductive physiology remains unexplored. Emerging evidence—including the detection of GGA in testis, epididymis, prostate, and even human seminal fluid—suggests a physiological presence in the male reproductive tract. Furthermore, dietary GGA supplementation in mice has been linked to increased offspring survival. These findings prompt the hypothesis that GGA acts as a lipid-derived modulator of male fertility, influencing sperm maturation, local signaling, or fertilization capacity. Here, we explore this hypothesis through the lens of GGA’s biosynthesis, tissue distribution, receptor interactions, and possible eicosanoid-like signaling roles. We propose experimental strategies, ranging from lipidomic profiling to receptor screening and functional assays, to validate the physiological and reproductive relevance of this underrecognized metabolite.
No takes yet. Share an insight, caveat, or question.
Yuki Tabata (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: